Importance: Acid suppressants inhibit gastric acid secretion and disrupt the intestinal microbiome. Whether acid suppression increases the risk of colonization with multidrug-resistant microorganisms (MDROs) is unclear. Objectives: To systematically examine the association of use of acid suppressants with the risk of colonization with MDROs and to perform a meta-analysis of current evidence. Data Sources: PubMed, Embase, the Web of Science Core Collection, and the Cochrane Central Register of Controlled Trials were searched from database inception through July 8, 2019. Study Selection: Study selection was performed independently by 2 authors (R.P.J.W. and C.M.J.E.V.-G.) on the basis of predefined selection criteria; conflicts were resolved ...
Background: Carriers of multidrug-resistant bacteria are at risk of infections with these bacteria; ...
Aims: To investigate whether acid suppression medicines (ASMs) increase the risk of bacterial gastro...
BACKGROUND: Long-term acid suppression may accelerate the development of atrophic gastritis in Helic...
BACKGROUND: Gastric acid-suppressive therapy has been suggested to increase the risk for intestinal ...
Long-term use of gastric-acid-suppressive drugs is known to be associated with several adverse effec...
BACKGROUND: Bacteria and viruses have been detected in the stomach of patients during acid-suppressi...
BACKGROUND: Intragastric growth of non-Helicobacter pylori bacteria commonly occurs during acid-supp...
Purpose of review We reviewed recent clinical studies performed in adults, children, and neonates ex...
Objective: Proton pump inhibitors (PPIs) are drugs used to suppress gastric acid production and trea...
BACKGROUND: Evidence for the association between Clostridium difficile (C. difficile) and the use of...
Purpose of reviewThe discovery of Helicobacter pylori and other organisms colonizing the stomach and...
Background: Carriers of multidrug-resistant bacteria are at risk of infections with these bacteria; ...
Aims: To investigate whether acid suppression medicines (ASMs) increase the risk of bacterial gastro...
BACKGROUND: Long-term acid suppression may accelerate the development of atrophic gastritis in Helic...
BACKGROUND: Gastric acid-suppressive therapy has been suggested to increase the risk for intestinal ...
Long-term use of gastric-acid-suppressive drugs is known to be associated with several adverse effec...
BACKGROUND: Bacteria and viruses have been detected in the stomach of patients during acid-suppressi...
BACKGROUND: Intragastric growth of non-Helicobacter pylori bacteria commonly occurs during acid-supp...
Purpose of review We reviewed recent clinical studies performed in adults, children, and neonates ex...
Objective: Proton pump inhibitors (PPIs) are drugs used to suppress gastric acid production and trea...
BACKGROUND: Evidence for the association between Clostridium difficile (C. difficile) and the use of...
Purpose of reviewThe discovery of Helicobacter pylori and other organisms colonizing the stomach and...
Background: Carriers of multidrug-resistant bacteria are at risk of infections with these bacteria; ...
Aims: To investigate whether acid suppression medicines (ASMs) increase the risk of bacterial gastro...
BACKGROUND: Long-term acid suppression may accelerate the development of atrophic gastritis in Helic...